Zebra Medical Vision said today that it won FDA 510(k) clearance for its HealthPNX artificial intelligence-powered pneumothorax alerting system designed to analyze chest X-rays.
The Israel-based developer said that the newly cleared technology is designed to automatically detect findings suggestive of pneumothorax based on chest x-rays or digital radiography scans, and to alert physicians of the condition.
“In a clinical validation study we performed, Zebra-Med’s acute CXR pneumothorax and CT Brain bleed products demonstrated a promising potential to substantially reduce turnaround time and increase the radiologist’s confidence in making these diagnoses,” Dr. Terence Matalon of the Albert Einstein Medical Center said in a press release.
Zebra Medical Vision touted the FDA clearance as the first of it’s kind, estimating that the system could save physicians more than 80% of the time required to reach an acute condition compared to a traditional first in first out methodology.
The company said that its chest X-ray AI network was trained using millions of images to identify more than 40 common clinical findings.
“We are happy to add this important capability to our All-in-One package and add more value to busy radiology departments. Health providers across the U.S. that already use the many Zebra-integrated PACS and worklist systems, will be able to easily deploy our triage solution and improve their patients’ care and outcomes,” co-founder & CEO Eyal Gura said in a prepared statement.
The clearance follows a previously received FDA approval won last July for a Coronary Calcium Scoring algorithm.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.